Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
JMP Securities, Astria Therapeutics
JMP Securities maintains AN2 Therapeutics stock with $5 target
JMP Securities reiterated its Market Outperform rating on AN2 Therapeutics (NASDAQ:ANTX) shares, maintaining a $5.00 price target, representing significant upside from the current price of $1.14. According to InvestingPro data,
Astria Therapeutics initiated with an Outperform at JMP Securities
JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics (ATXS) with an Outperform rating and $26 price target
JMP Securities Initiates Coverage of Astria Therapeutics (ATXS) with Market Outperform Recommendation
Fintel reports that on January 31, 2025, JMP Securities initiated coverage of Astria Therapeutics (NasdaqGM:ATXS) with a Market Outperform recommendation. Analyst Price Forecast Suggests 244.82% Upside As of January 29,
JMP Securities maintains Roku stock with $95 target
JMP Securities reaffirmed its Market Outperform rating on Roku Inc. (NASDAQ:ROKU) with a steady price target of $95.00. According to InvestingPro data, Roku's stock has shown significant momentum with a 56% gain over the past six months,
5h
JMP Securities Keeps Their Buy Rating on nCino (NCNO)
JMP Securities analyst Aaron Kimson maintained a Buy rating on nCino (NCNO – Research Report) today and set a price target of $43.00. The ...
18d
Metro Detroit Little Caesars franchisee fined $26K for violating child labor laws
Investigators reportedly found that JMP Pizza Inc. allowed three children to work longer and later hours than laws permit.
Yahoo Finance
25d
JMP Expects a ‘Value-Creating Year’ for These 2 High-Yield Dividend Stocks
Covering some solid dividend stocks for
JMP
, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...
15h
JMP Securities Reaffirms Their Buy Rating on GH Research (GHRS)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on GH Research (GHRS – Research Report), with a price ...
3d
on MSN
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
6d
on MSN
Cloudflare, CyberArk see price targets raised at JMP ahead of earnings
JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...
9d
Option Care Health price target raised to $35 from $30 at JMP Securities
JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...
6d
on MSN
Cloudflare, Inc. (NET) Gets Price Target Upgrades from JMP and Truist Ahead of Q4 Earnings
In this article, we are going to take a look at where Cloudflare, Inc. (NYSE:NET) stands against the other AI stocks. AI is ...
1d
JMP Securities Sticks to Their Hold Rating for Axis Capital (AXS)
JMP Securities analyst Matthew Carletti reiterated a Hold rating on Axis Capital (AXS – Research Report) today. The company’s shares closed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ai
New York Stock Exchange
Roku
Microsoft
Trade
Feedback